Current status of antitumor therapy with monoclonal antibodies.
The potential power of monoclonal antibodies arises from their ability to recognize single antigenic determinants in a complex mixture of molecules or cells. The possibilities for cancer therapy are apparent. But to what extent has the potential been realized? What problems have arisen in clinical trials?
Scheinberg
D A
DA
Memorial Sloan-Kettering Cancer Center.
Houghton
A N
AN
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D000922:Immunotoxins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000922:Immunotoxins